Next Science Limited (ASX: NXS) is a medical technology company headquartered in Sydney, Australia, with commercial operations in Florida, USA. Next Science’s primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human health.

Reporting Calendar

Reporting date Details of report
January Q4 Activity & Cashflow Reports
February Full Year Financial Report for previous year
April Q1 Activity & Cashflow Reports.
Annual Report
May Annual General Meeting
July Q2 Activity & Cashflow Reports
August Half-Year Report
October Q3 Activity & Cashflow Reports

Investor contacts

Investor queries

Next Science Limited
Level 14, Australia Square,
264-278 George Street, Sydney
NSW 2000
Ph: +61 412 292 977
E: [email protected]

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474